Nadler Financial Group Inc. Makes New $278,000 Investment in CME Group Inc. (NASDAQ:CME)

Nadler Financial Group Inc. bought a new position in shares of CME Group Inc. (NASDAQ:CME - Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm bought 1,197 shares of the financial services provider's stock, valued at approximately $278,000.

A number of other institutional investors have also recently bought and sold shares of the stock. Truvestments Capital LLC acquired a new stake in shares of CME Group in the third quarter valued at about $26,000. SJS Investment Consulting Inc. increased its position in shares of CME Group by 570.6% during the 4th quarter. SJS Investment Consulting Inc. now owns 114 shares of the financial services provider's stock worth $26,000 after purchasing an additional 97 shares during the last quarter. Dunhill Financial LLC increased its position in shares of CME Group by 188.4% during the 3rd quarter. Dunhill Financial LLC now owns 124 shares of the financial services provider's stock worth $27,000 after purchasing an additional 81 shares during the last quarter. Fortitude Family Office LLC raised its stake in shares of CME Group by 120.3% during the 4th quarter. Fortitude Family Office LLC now owns 152 shares of the financial services provider's stock worth $35,000 after purchasing an additional 83 shares in the last quarter. Finally, Thurston Springer Miller Herd & Titak Inc. boosted its holdings in shares of CME Group by 62.2% in the 3rd quarter. Thurston Springer Miller Herd & Titak Inc. now owns 193 shares of the financial services provider's stock valued at $43,000 after buying an additional 74 shares during the last quarter. Institutional investors own 87.75% of the company's stock.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on CME shares. Morgan Stanley boosted their target price on shares of CME Group from $210.00 to $233.00 and gave the stock an "equal weight" rating in a report on Thursday, October 17th. Keefe, Bruyette & Woods lowered their price objective on shares of CME Group from $260.00 to $256.00 and set a "market perform" rating on the stock in a research note on Monday, January 13th. Barclays raised their target price on shares of CME Group from $231.00 to $257.00 and gave the company an "equal weight" rating in a research note on Monday, December 9th. Oppenheimer boosted their price target on CME Group from $245.00 to $258.00 and gave the stock an "outperform" rating in a research report on Thursday, October 24th. Finally, Royal Bank of Canada reaffirmed a "sector perform" rating and issued a $235.00 price objective on shares of CME Group in a research report on Monday, January 6th. Four analysts have rated the stock with a sell rating, eight have given a hold rating and three have given a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of "Hold" and an average price target of $229.27.

CME Group Stock Performance

Shares of CME stock traded up $0.60 on Friday, hitting $236.52. The company's stock had a trading volume of 1,981,697 shares, compared to its average volume of 1,754,316. CME Group Inc. has a fifty-two week low of $190.70 and a fifty-two week high of $249.02. The company has a debt-to-equity ratio of 0.09, a quick ratio of 1.02 and a current ratio of 1.02. The stock's 50 day moving average is $234.73 and its 200-day moving average is $222.63. The company has a market capitalization of $85.23 billion, a PE ratio of 24.87, a PEG ratio of 5.28 and a beta of 0.56.

CME Group Increases Dividend

The firm also recently announced a dividend, which was paid on Thursday, January 16th. Stockholders of record on Friday, December 27th were issued a dividend of $5.80 per share. The ex-dividend date was Friday, December 27th. This is a boost from CME Group's previous dividend of $2.50. CME Group's dividend payout ratio (DPR) is currently 48.37%.

CME Group announced that its board has initiated a stock buyback program on Thursday, December 5th that permits the company to buyback $3.00 billion in outstanding shares. This buyback authorization permits the financial services provider to reacquire up to 3.4% of its stock through open market purchases. Stock buyback programs are often a sign that the company's management believes its stock is undervalued.

Insider Activity

In other CME Group news, Director Martin J. Gepsman sold 400 shares of the firm's stock in a transaction dated Monday, November 4th. The shares were sold at an average price of $222.92, for a total value of $89,168.00. Following the transaction, the director now directly owns 25,067 shares of the company's stock, valued at $5,587,935.64. This trade represents a 1.57 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.30% of the stock is owned by company insiders.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.